Temporin-1Sa, SEQ ID NO:1 for Patent EP 2853538 A1

General Information


DRACP ID  DRACP02399

Peptide Name   Temporin-1Sa, SEQ ID NO:1 for Patent EP 2853538 A1

Sequence  FLSGIVGMLGKLE

Sequence Length  13

UniProt ID  B3KYH4 

PubChem CID  Not available

Origin  Pelophylax saharicus (Sahara frog) (Rana saharica)

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
THP-1 Childhood acute monocytic leukemia; Acute monoblastic/monocytic leukemia Leukemia IC50>60 μM MTT assay 72 h Patent
HepG2 Hepatoblastoma Blastoma LC50=560 μM MTT assay 72 h Patent

Hemolytic Activity  Rat erythrocytes: LC50=25 µM

Normal (non-cancerous) Cytotoxicity  Human fibroblasts: LC50>100 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02399

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C63H106N14O17S

Absent amino acids  ACDHNPQRTWY

Common amino acids  GL

Mass  157791

Pl  6.41

Basic residues  1

Acidic residues  1

Hydrophobic residues  6

Net charge  0

Boman Index  1611

Hydrophobicity  118.46

Aliphatic Index  142.31

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID EP 2853538 A1

Patent Title  Analogues of temporin-SHa and uses thereof

Other Iinformation  Patent Application; Family: 11s / 11ex; Family Jurisdictions: CA, EP, JP, BR, US, WO, ES; Legal Status: Discontinued; Application No: 13306344; Filed: Sep 27, 2013; Published: Apr 1, 2015; Earliest Priority: Sep 27, 2013

Other Published ID  BR112016006424A2  CA2924035A1  EP3049432A1  EP3049432B1  ES2691323T3  JP2016539658A  JP6669656B2  US2016280749A1  US9932376B2  WO2015044356A1 




DRACP is developed by Dr.Zheng's team.